Home/Pipeline/IMW‑001

IMW‑001

Type‑2 Diabetes

Phase 1Active

Key Facts

Indication

Type‑2 Diabetes

Phase

Phase 1

Status

Active

Company

About Immunwork

Taiwan biotech creating ultra‑long‑acting endocrine drugs and antibody‑based oncology candidates.

View full company profile

Therapeutic Areas

Endocrinology Oncology

Other Type‑2 Diabetes Drugs

Drug	Company	Phase	Status
AGS‑499	Neuromagen Pharma	Preclinical	Active